Evaluate Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Indicator: In combination with chemotherapy, with the remedy of Grownup sufferers with domestically recurrent unresectable or metastatic triple-adverse breast most cancers that have not been given prior chemotherapy for metastatic illness and whose tumours Categorical programmed cel… Read More